A drug status update affecting Australian patients involves Ipsen and AstraZeneca, with changes made to the Pharmaceutical Benefits Scheme (PBS) on September 1, 2026.
1 report, 1 independent
Updated Sep 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A drug status update affecting Australian patients involves Ipsen and AstraZeneca, with changes made to the Pharmaceutical Benefits Scheme (PBS) on September 1, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ipsen
company in Barcelona, Spain
Nothing else this week.
-
AstraZeneca
British-Swedish pharmaceutical company